1
|
Geertsema S, Jansen BH, van Goor H, Dijkstra G, Faber KN, Bourgonje AR. Unsuitability of the Oxidation-Reduction Potential Measurement for the Quantification of Fecal Redox Status in Inflammatory Bowel Disease. Biomedicines 2023; 11:3107. [PMID: 38137328 PMCID: PMC10741202 DOI: 10.3390/biomedicines11123107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 10/27/2023] [Accepted: 11/01/2023] [Indexed: 12/24/2023] Open
Abstract
Oxidative stress is a key pathophysiological process associated with the development and progression of inflammatory bowel disease (IBD). Biomarkers for oxidative stress, however, are scarce, as are diagnostic tools that can interrogate an individual's gut redox status. This proof-of-concept study aimed to evaluate the potential utility of an oxidation-reduction potential (ORP) measurement probe, to quantify redox status in the feces of both patients with IBD and healthy controls. Previous studies using this ORP measurement probe demonstrated promising data when comparing ORP from severely malnourished individuals with that of healthy controls. To date, ORP analyses have not been performed in the context of IBD. We hypothesized that measuring the ORP of fecal water in patients with IBD might have diagnostic value. The current study, however, did not show significant differences in ORP measurement values between patients with IBD (median [IQR] 46.5 [33.0-61.2] mV) and healthy controls (25 [8.0-52.0] mV; p = 0.221). Additionally, ORP measurements were highly unstable and rapidly fluctuated throughout time, with ORP values varying from +24 to +303 mV. Due to potential biological processes and limitations of the measuring equipment, this study was unable to reliably measure ORP. As a result, our findings indicate that ORP quantification may not be a suitable method for assessing fecal redox status and, therefore, does not currently support further exploration as a diagnostic or monitoring tool.
Collapse
Affiliation(s)
- Sem Geertsema
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands; (S.G.); (B.H.J.); (G.D.); (K.N.F.)
| | - Bernadien H. Jansen
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands; (S.G.); (B.H.J.); (G.D.); (K.N.F.)
| | - Harry van Goor
- Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands;
| | - Gerard Dijkstra
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands; (S.G.); (B.H.J.); (G.D.); (K.N.F.)
| | - Klaas Nico Faber
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands; (S.G.); (B.H.J.); (G.D.); (K.N.F.)
| | - Arno R. Bourgonje
- Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands; (S.G.); (B.H.J.); (G.D.); (K.N.F.)
- The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| |
Collapse
|
2
|
Bourg P, Salottolo K, Klein J, Bar-Or D. Can a biomarker for oxidative stress and antioxidant reserves identify frailty in geriatric trauma patients? Injury 2021; 52:2908-2913. [PMID: 33573809 DOI: 10.1016/j.injury.2021.01.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Revised: 01/28/2021] [Accepted: 01/30/2021] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Frailty is a state of systematic physiologic decline and reduced ability to recover from illness. There are no rapid quantitative biological measures to assess frailty. The study objective was to determine whether oxidation-reduction potential (ORP) is correlated with frailty score. METHODS This prospective, observational cohort study was performed using plasma samples of geriatric trauma patients (≥65 years) admitted to a level I trauma center. Frailty was measured with the Canadian Study of Health and Aging (CSHA) Clinical Frailty Scale (7-point scale; 1 = robust health and 7 = severely frail). Plasma ORP was determined using the RedoxSYS™ system to measure static ORP (aggregate measure of oxidative stress) and capacity ORP (antioxidant reserves; log transformed). Spearman rank correlation (presented as rs) and ordinal logistic regression (presented as adjusted odds ratios, AOR) were used to examine the unadjusted and adjusted relationship between frailty score and ORP values. RESULTS There were 93 geriatric trauma patients in our study. The majority (86%) had frailty scores 1-5, 11% were moderately frail and 3% were severely frail. There was a u-shaped relationship between ORP and frailty scale that became monotonic for scores 1-5. Each increase in frailty score demonstrated significant decreases in antioxidant reserves (log cORP rs = -0.26, p = 0.02) and nonsignificant increases in oxidative stress (sORP rs = 0.17, p = 0.15). After adjustment, variables significantly associated with frailty included log cORP (e.g., fewer antioxidant reserves, AOR: 0.70), age (AOR: 1.82), injury severity score (AOR: 0.50), admission lactate ≥2.5 mMol (AOR: 4.31), and alcohol use (AOR: 0.34). CONCLUSIONS The amount of antioxidant reserves (cORP) appears to be a quantitative marker to differentiate the degree of frailty ranging from robust health to mild frailty in geriatric trauma patients. We propose that direct quantification of frailty by way of a biomarker for oxidative reserves could have application in emergent trauma situations.
Collapse
Affiliation(s)
| | | | | | - David Bar-Or
- Trauma Research Department, St Anthony Hospital, Lakewood, CO; Rocky Vista University, Parker, CO.
| |
Collapse
|
3
|
Rozemeijer S, Smit B, Elbers PWG, Girbes ARJ, Oudemans-van Straaten HM, de Man AME. Rapid screening of critically ill patients for low plasma vitamin C concentrations using a point-of-care oxidation-reduction potential measurement. Intensive Care Med Exp 2021; 9:40. [PMID: 34368931 PMCID: PMC8349944 DOI: 10.1186/s40635-021-00403-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Accepted: 07/07/2021] [Indexed: 11/11/2022] Open
Abstract
Background Hypovitaminosis C and vitamin C deficiency are common in critically ill patients and associated with organ dysfunction. Low vitamin C status often goes unnoticed because determination is challenging. The static oxidation reduction potential (sORP) reflects the amount of oxidative stress in the blood and is a potential suitable surrogate marker for vitamin C. sORP can be measured rapidly using the RedoxSYS system, a point-of-care device. This study aims to validate a model that estimates plasma vitamin C concentration and to determine the diagnostic accuracy of sORP to discriminate between decreased and higher plasma vitamin C concentrations. Methods Plasma vitamin C concentrations and sORP were measured in a mixed intensive care (IC) population. Our model estimating vitamin C from sORP was validated by assessing its accuracy in two datasets. Receiver operating characteristic (ROC) curves with areas under the curve (AUC) were constructed to show the diagnostic accuracy of sORP to identify and rule out hypovitaminosis C and vitamin C deficiency. Different cut-off values are provided. Results Plasma vitamin C concentration and sORP were measured in 117 samples in dataset 1 and 43 samples in dataset 2. Bias and precision (SD) were 1.3 ± 10.0 µmol/L and 3.9 ± 10.1 µmol/L in dataset 1 and 2, respectively. In patients with low plasma vitamin C concentrations, bias and precision were − 2.6 ± 5.1 µmol/L and − 1.1 ± 5.4 µmol in dataset 1 (n = 40) and 2 (n = 20), respectively. Optimal sORP cut-off values to differentiate hypovitaminosis C and vitamin C deficiency from higher plasma concentrations were found at 114.6 mV (AUC 0.91) and 124.7 mV (AUC 0.93), respectively. Conclusion sORP accurately estimates low plasma vitamin C concentrations and can be used to screen for hypovitaminosis C and vitamin C deficiency in critically ill patients. A validated model and multiple sORP cut-off values are presented for subgroup analysis in clinical trials or usage in clinical practice. Supplementary Information The online version contains supplementary material available at 10.1186/s40635-021-00403-w.
Collapse
Affiliation(s)
- Sander Rozemeijer
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .,Research VUmc Intensive Care (REVIVE), 1081 HV, Amsterdam, The Netherlands. .,Amsterdam Medical Data Science (AMDS), 1081 HV, Amsterdam, The Netherlands. .,Amsterdam Cardiovascular Science (ACS), 1081 HV, Amsterdam, The Netherlands. .,Amsterdam Infection and Immunity (AII), 1081 HV, Amsterdam, The Netherlands.
| | - Bob Smit
- LabWest, Haga Teaching Hospital, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands
| | - Paul W G Elbers
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.,Research VUmc Intensive Care (REVIVE), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Medical Data Science (AMDS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Cardiovascular Science (ACS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Infection and Immunity (AII), 1081 HV, Amsterdam, The Netherlands
| | - Armand R J Girbes
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.,Research VUmc Intensive Care (REVIVE), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Medical Data Science (AMDS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Cardiovascular Science (ACS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Infection and Immunity (AII), 1081 HV, Amsterdam, The Netherlands
| | - Heleen M Oudemans-van Straaten
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.,Research VUmc Intensive Care (REVIVE), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Medical Data Science (AMDS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Cardiovascular Science (ACS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Infection and Immunity (AII), 1081 HV, Amsterdam, The Netherlands
| | - Angelique M E de Man
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.,Research VUmc Intensive Care (REVIVE), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Medical Data Science (AMDS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Cardiovascular Science (ACS), 1081 HV, Amsterdam, The Netherlands.,Amsterdam Infection and Immunity (AII), 1081 HV, Amsterdam, The Netherlands
| |
Collapse
|
4
|
Rozemeijer S, Spoelstra-de Man AME, Coenen S, Smit B, Elbers PWG, de Grooth HJ, Girbes ARJ, Oudemans-van Straaten HM. Estimating Vitamin C Status in Critically Ill Patients with a Novel Point-of-Care Oxidation-Reduction Potential Measurement. Nutrients 2019; 11:nu11051031. [PMID: 31071996 PMCID: PMC6566553 DOI: 10.3390/nu11051031] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2019] [Revised: 04/30/2019] [Accepted: 05/02/2019] [Indexed: 12/22/2022] Open
Abstract
Vitamin C deficiency is common in critically ill patients. Vitamin C, the most important antioxidant, is likely consumed during oxidative stress and deficiency is associated with organ dysfunction and mortality. Assessment of vitamin C status may be important to identify patients who might benefit from vitamin C administration. Up to now, vitamin C concentrations are not available in daily clinical practice. Recently, a point-of-care device has been developed that measures the static oxidation-reduction potential (sORP), reflecting oxidative stress, and antioxidant capacity (AOC). The aim of this study was to determine whether plasma vitamin C concentrations were associated with plasma sORP and AOC. Plasma vitamin C concentration, sORP and AOC were measured in three groups: healthy volunteers, critically ill patients, and critically ill patients receiving 2- or 10-g vitamin C infusion. Its association was analyzed using regression models and by assessment of concordance. We measured 211 samples obtained from 103 subjects. Vitamin C concentrations were negatively associated with sORP (R2 = 0.816) and positively associated with AOC (R2 = 0.842). A high concordance of 94–100% was found between vitamin C concentration and sORP/AOC. Thus, plasma vitamin C concentrations are strongly associated with plasma sORP and AOC, as measured with a novel point-of-care device. Therefore, measuring sORP and AOC at the bedside has the potential to identify and monitor patients with oxidative stress and vitamin C deficiency.
Collapse
Affiliation(s)
- Sander Rozemeijer
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Angélique M E Spoelstra-de Man
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Sophie Coenen
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Bob Smit
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Paul W G Elbers
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Harm-Jan de Grooth
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Armand R J Girbes
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| | - Heleen M Oudemans-van Straaten
- Department of Intensive Care Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Research VUmc Intensive Care (REVIVE), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Science (ACS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Medical Data Science (AMDS), 1081 HV Amsterdam, The Netherlands.
- Amsterdam Infection and Immunity Institute (AI&II), 1081 HV Amsterdam, The Netherlands.
| |
Collapse
|